These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 35803208)
1. Identification of expression of CCND1-related lncRNAs in breast cancer. Hussen BM; Hidayat HJ; Ghafouri-Fard S Pathol Res Pract; 2022 Aug; 236():154009. PubMed ID: 35803208 [TBL] [Abstract][Full Text] [Related]
2. Expression analysis of autophagy-related long non-coding RNAs in Iranian patients with breast cancer. Safarzadeh A; Akhavan-Bahabadi M; Hussen BM; Nicknam A; Eslami S; Pouresmaeili F; Ghafouri-Fard S; Taheri M Pathol Res Pract; 2022 Nov; 239():154146. PubMed ID: 36195025 [TBL] [Abstract][Full Text] [Related]
3. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer. Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323 [TBL] [Abstract][Full Text] [Related]
4. Expression analysis of Rho GTPase-related lncRNAs in breast cancer. Nicknam A; Khojasteh Pour S; Hashemnejad MA; Hussen BM; Safarzadeh A; Eslami S; Taheri M; Ghafouri-Fard S; Jamali E Pathol Res Pract; 2023 Apr; 244():154429. PubMed ID: 36996609 [TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker. Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer. Zhang Y; Wang DL; Yan HY; Liao JY; He JH; Hu KS; Deng WX; Wang YJ; Xing HT; Koeffler HP; Yin D Oncol Rep; 2017 Nov; 38(5):3227-3237. PubMed ID: 29048636 [TBL] [Abstract][Full Text] [Related]
7. LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells. Shi X; Wang X FEBS Lett; 2019 Apr; 593(7):751-759. PubMed ID: 30848493 [TBL] [Abstract][Full Text] [Related]
8. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers. Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M- Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of a panel of immune-related lncRNAs in breast cancer. Ghafouri-Fard S; Asadi M; Sohrabi B; Arsang-Jang S; Mehravaran E; Taheri M; Samsami M Pathol Res Pract; 2021 Aug; 224():153534. PubMed ID: 34175685 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis. Guo F; Fu Q; Wang Y; Sui G J Cell Mol Med; 2019 Sep; 23(9):5907-5919. PubMed ID: 31304680 [TBL] [Abstract][Full Text] [Related]
11. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer. Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487 [TBL] [Abstract][Full Text] [Related]
12. In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples. Dashti S; Taherian-Esfahani Z; Kholghi-Oskooei V; Noroozi R; Arsang-Jang S; Ghafouri-Fard S; Taheri M Sci Rep; 2020 May; 10(1):8316. PubMed ID: 32433496 [TBL] [Abstract][Full Text] [Related]
13. LncRNA FOXD2-AS1 regulates chondrocyte proliferation in osteoarthritis by acting as a sponge of miR-206 to modulate CCND1 expression. Cao L; Wang Y; Wang Q; Huang J Biomed Pharmacother; 2018 Oct; 106():1220-1226. PubMed ID: 30119190 [TBL] [Abstract][Full Text] [Related]
14. LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1. Ai B; Kong X; Wang X; Zhang K; Yang X; Zhai J; Gao R; Qi Y; Wang J; Wang Z; Fang Y Cell Death Dis; 2019 Jun; 10(7):502. PubMed ID: 31243265 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of SLC16A-AS1 and LINC00900 lncRNAs in Iranian patients with breast cancer. Dorostgoo Z; Fattahi AS; Moosavi SS; Ghafouri-Fard S; Oskooei VK Breast Dis; 2022; 41(1):521-528. PubMed ID: 36641651 [TBL] [Abstract][Full Text] [Related]
16. Expression analysis of vimentin and the related lncRNA network in breast cancer. Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061 [TBL] [Abstract][Full Text] [Related]
17. Expression analysis of PPAR-related lncRNAs in breast cancer. Ghafouri-Fard S; Nicknam A; Safarzadeh A; Eslami S; Samsami M; Jamali E Pathol Res Pract; 2023 Nov; 251():154844. PubMed ID: 37820438 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1. Long B; Li N; Xu XX; Li XX; Xu XJ; Liu JY; Wu ZH Biochem Biophys Res Commun; 2018 Oct; 505(2):561-568. PubMed ID: 30278884 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer. Shao X; Huang P; Shi L; Lei L; Cao W; Chen Z; Wang X; Zheng Y Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775882 [TBL] [Abstract][Full Text] [Related]
20. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis. Liu X; Yao W; Xiong H; Li Q; Li Y Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]